Rite Aid (RAD) Tops Q2 EPS by 2c; Comps Flat; Issues FY12 Revs Outlook
Tweet
Share
E-mailGet Alerts RAD Hot Sheet
Price: $0.65 --0%
Financial Fact:
Selling, general and administrative expenses: 1.78B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative expenses: 1.78B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Rite Aid (NYSE: RAD) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.2 billion.
Same store sales for the quarter were flat over the prior year 13-week period, consisting of a 1.4 percent increase in front end sales offset by a 0.7 percent decrease in pharmacy sales.
Rite Aid sees FY2012 revenue of $25.1-25.4 billion, versus the consensus of $25.4 billion.
For earnings history and earnings-related data on Rite Aid (RAD) click here.
Same store sales for the quarter were flat over the prior year 13-week period, consisting of a 1.4 percent increase in front end sales offset by a 0.7 percent decrease in pharmacy sales.
Rite Aid sees FY2012 revenue of $25.1-25.4 billion, versus the consensus of $25.4 billion.
For earnings history and earnings-related data on Rite Aid (RAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
